Tyrese Maxey: Everything you need to know

Tyrese Maxey

Philadelphia 76ers

Status

ACTIVE

STATS

Career Averages

PTS

REB

AST

BLK

STL

21.1

3.2

4.8

0.4

1.1

Year	GP	GS	MIN	PTS	REB	AST	BLK	STL	TO	DD2	TD3	3PM	3PA	3P%	2PM	2PA	2P%	FGM	FGA	FG%	FTM	FTA	FT%	OREB	DREB	PF	A/TO	+/-	TS%
2025-26	70	70	38.0	28.3	4.1	6.6	0.8	1.9	2.4	7	0	3.1	8.6	36.7%	6.8	12.9	52.5%	9.9	21.4	46.2%	5.3	6.0	89.2%	0.3	3.8	2.2	2.7	+113	58.8%
2024-25	52	52	37.7	26.3	3.3	6.1	0.4	1.8	2.4	8	1	3.1	9.2	33.7%	6.1	11.8	51.5%	9.2	21.0	43.7%	4.9	5.6	87.9%	0.3	3.1	2.2	2.6	-124	56.2%
2023-24	70	70	37.5	25.9	3.7	6.2	0.5	1.0	1.7	9	0	3.0	8.1	37.3%	6.1	12.1	50.1%	9.1	20.3	45.0%	4.7	5.4	86.8%	0.5	3.2	2.2	3.7	+303	57.3%
2022-23	60	41	33.6	20.3	2.9	3.5	0.1	0.8	1.3	0	0	2.7	6.2	43.4%	4.7	9.1	51.3%	7.3	15.2	48.1%	3.0	3.6	84.5%	0.4	2.6	2.2	2.7	+241	60.5%
2021-22	75	74	35.3	17.5	3.2	4.3	0.4	0.7	1.2	1	0	1.8	4.1	42.7%	4.7	9.1	51.2%	6.4	13.3	48.5%	2.8	3.3	86.6%	0.3	2.9	2.1	3.6	+192	59.4%
2020-21	61	8	15.3	8.0	1.7	2.0	0.2	0.4	0.7	0	0	0.5	1.7	30.1%	2.7	5.3	51.2%	3.2	7.0	46.2%	1.0	1.1	87.1%	0.2	1.5	1.3	2.9	-52	53.1%
Career	388	315	33.1	21.1	3.2	4.8	0.4	1.1	1.6	25	1	2.4	6.3	37.7%	5.2	10.1	51.3%	7.5	16.4	46.1%	3.6	4.2	87.3%	0.3	2.9	2.0	3.0	+673	58.0%

Career Averages

PTS

REB

AST

BLK

STL

19.0

3.8

3.6

0.4

0.8

Year	GP	GS	MIN	PTS	REB	AST	BLK	STL	TO	DD2	3PM	3PA	3P%	2PM	2PA	2P%	FGM	FGA	FG%	FTM	FTA	FT%	OREB	DREB	PF	A/TO	+/-	TS%
2025-26	8	8	39.1	25.1	4.6	6.0	0.5	0.9	1.6	2	2.9	7.3	39.7%	6.3	12.8	49.0%	9.1	20.0	45.6%	4.0	4.1	97.0%	0.5	4.1	2.1	3.7	-40	57.6%
2023-24	6	6	44.5	29.8	5.2	6.8	0.3	0.8	2.2	1	3.7	9.2	40.0%	7.3	13.8	53.0%	11.0	23.0	47.8%	4.2	4.7	89.3%	0.2	5.0	2.7	3.2	-8	59.5%
2022-23	11	11	38.5	20.5	4.8	2.3	0.5	1.4	0.7	0	3.1	7.7	40.0%	4.4	9.7	44.9%	7.5	17.5	42.7%	2.5	2.8	90.3%	0.8	4.0	2.4	3.1	+4	55.0%
2021-22	12	12	40.4	20.8	3.5	3.9	0.2	0.8	1.8	0	2.2	5.8	37.7%	5.2	9.4	54.9%	7.3	15.2	48.4%	3.9	4.2	94.0%	0.5	3.0	2.0	2.2	+0	61.0%
2020-21	12	0	13.0	6.3	1.8	1.3	0.5	0.3	0.4	0	0.3	1.0	33.3%	2.1	4.5	46.3%	2.4	5.5	43.9%	1.2	1.8	63.6%	0.1	1.8	1.3	3.2	+11	50.2%
Career	49	37	33.6	19.0	3.8	3.6	0.4	0.8	1.2	3	2.2	5.7	39.1%	4.7	9.4	49.9%	6.9	15.1	45.8%	3.0	3.3	89.0%	0.4	3.3	2.0	3.0	-33	57.5%

Preseason
Date	Opp	Result	MIN	PTS	REB	AST	BLK	STL	TO	3PA	3PM	3P%	2PA	2PM	2P%	FGA	FGM	FG%	FTA	FTM	FT%	OREB	DREB	A/TO	+/-	PF	PER	TS%
10/10	ORL	L 128-98	12	17	0	2	0	0	0	6	3	50.0%	8	4	50.0%	14	7	50.0%	0	0	0.0%	0	0	0.0	-2	2	10	60.7%
10/4	NYK	L 113-104	17	16	2	2	0	1	1	7	3	42.9%	3	1	33.3%	10	4	40.0%	6	5	83.3%	1	1	2.0	-6	2	15	63.3%
10/2	NYK	L 99-84	23	14	4	4	1	1	5	4	0	0.0%	8	5	62.5%	12	5	41.7%	4	4	100.0%	0	4	0.8	-5	1	12	50.9%
Preseason Totals			17.6	15.7	2.0	2.7	0.3	0.7	2.0	5.7	2.0	35.3%	6.3	3.3	52.6%	12.0	5.3	44.4%	3.3	3.0	90.0%	0.3	1.7	1.3	-13	1.7	14.3	58.2%

Regular Season
Date	Opp	Result	MIN	PTS	REB	AST	BLK	STL	TO	3PA	3PM	3P%	2PA	2PM	2P%	FGA	FGM	FG%	FTA	FTM	FT%	OREB	DREB	A/TO	+/-	PF	PER	TS%
4/10	IND	W 105-94	38	32	8	5	0	2	1	10	1	10.0%	18	10	55.6%	28	11	39.3%	10	9	90.0%	3	5	5.0	+18	3	30	49.4%
4/9	HOU	L 113-102	33	24	3	5	0	0	2	10	5	50.0%	10	4	40.0%	20	9	45.0%	1	1	100.0%	1	2	2.5	-18	3	15	58.7%
4/6	SAS	L 115-102	39	15	3	8	0	0	4	4	1	25.0%	12	5	41.7%	16	6	37.5%	2	2	100.0%	1	2	2.0	-15	2	12	44.4%
4/4	DET	L 116-93	33	23	1	1	0	1	2	5	2	40.0%	12	6	50.0%	17	8	47.1%	7	5	71.4%	1	0	0.5	-27	2	12	57.3%
4/3	MIN	W 115-103	34	21	6	8	2	0	3	3	1	33.3%	10	6	60.0%	13	7	53.8%	6	6	100.0%	0	6	2.7	+14	1	29	67.1%
4/1	WAS	W 153-131	34	28	2	9	0	1	2	5	1	20.0%	15	11	73.3%	20	12	60.0%	4	3	75.0%	0	2	4.5	+28	1	31	64.3%
3/30	MIA	L 119-109	43	23	7	9	2	0	2	9	2	22.2%	11	5	45.5%	20	7	35.0%	7	7	100.0%	0	7	4.5	+1	5	25	49.8%
3/28	CHA	W 118-114	43	26	7	8	1	1	3	6	3	50.0%	12	7	58.3%	18	10	55.6%	4	3	75.0%	0	7	2.7	+13	2	31	65.8%
3/7	ATL	L 125-116	37	31	2	5	0	4	5	7	3	42.9%	15	9	60.0%	22	12	54.5%	4	4	100.0%	0	2	1.0	-10	3	27	65.2%
3/4	UTA	W 106-102	37	25	2	6	3	1	1	10	2	20.0%	12	6	50.0%	22	8	36.4%	7	7	100.0%	0	2	6.0	+8	0	26	49.8%
3/3	SAS	L 131-91	25	21	8	2	1	1	2	6	2	33.3%	13	6	46.2%	19	8	42.1%	4	3	75.0%	0	8	1.0	-36	0	22	50.6%
3/1	BOS	L 114-98	43	33	3	6	2	1	0	11	4	36.4%	23	8	34.8%	34	12	35.3%	6	5	83.3%	1	2	0.0	-9	1	22	45.0%
2/26	MIA	W 124-117	37	28	4	11	1	5	1	12	5	41.7%	14	4	28.6%	26	9	34.6%	5	5	100.0%	0	4	11.0	+6	2	31	49.6%
2/24	IND	W 135-114	33	32	9	8	1	2	2	8	2	25.0%	14	8	57.1%	22	10	45.5%	10	10	100.0%	1	8	4.0	+21	2	41	60.6%
2/22	MIN	W 135-108	35	39	3	8	1	2	5	7	4	57.1%	21	12	57.1%	28	16	57.1%	5	3	60.0%	1	2	1.6	+21	2	32	64.6%
2/21	NOP	L 126-111	36	27	3	7	0	5	5	11	2	18.2%	12	7	58.3%	23	9	39.1%	8	7	87.5%	1	2	1.4	-4	2	23	50.9%
2/19	ATL	L 117-107	38	28	3	3	1	1	2	11	4	36.4%	12	4	33.3%	23	8	34.8%	8	8	100.0%	0	3	1.5	-7	2	19	52.8%
2/11	NYK	L 138-89	32	32	2	2	0	1	1	8	3	37.5%	13	6	46.2%	21	9	42.9%	13	11	84.6%	0	2	2.0	-26	4	25	59.9%
2/9	POR	L 135-118	32	30	1	4	0	1	4	9	2	22.2%	12	8	66.7%	21	10	47.6%	8	8	100.0%	0	1	1.0	-22	4	20	61.2%
2/7	PHX	W 109-103	39	29	9	6	0	1	3	10	3	30.0%	11	5	45.5%	21	8	38.1%	11	10	90.9%	0	9	2.0	+14	2	32	56.1%
2/5	LAL	L 119-115	37	26	0	13	0	4	4	9	1	11.1%	13	10	76.9%	22	11	50.0%	4	3	75.0%	0	0	3.3	+8	5	24	54.7%
2/3	GSW	W 113-94	33	14	4	3	0	2	1	5	1	20.0%	4	2	50.0%	9	3	33.3%	7	7	100.0%	0	4	3.0	+14	1	19	57.9%
2/2	LAC	W 128-113	35	29	5	6	0	3	1	14	7	50.0%	4	2	50.0%	18	9	50.0%	4	4	100.0%	0	5	6.0	+22	4	31	73.4%
1/31	NOP	W 124-114	35	18	5	8	0	1	1	9	4	44.4%	9	3	33.3%	18	7	38.9%	0	0	0.0%	0	5	8.0	+5	3	14	50.0%
1/29	SAC	W 113-111	40	40	4	8	0	1	2	9	4	44.4%	9	8	88.9%	18	12	66.7%	13	12	92.3%	0	4	4.0	+8	3	50	84.3%
1/27	MIL	W 139-122	36	22	3	9	0	0	1	8	2	25.0%	11	7	63.6%	19	9	47.4%	2	2	100.0%	1	2	9.0	+5	2	21	55.3%
1/26	CHA	L 130-93	25	6	2	7	0	0	3	3	0	0.0%	9	3	33.3%	12	3	25.0%	0	0	0.0%	1	1	2.3	-36	0	4	25.0%
1/24	NYK	L 112-109	38	22	3	6	1	2	3	7	3	42.9%	8	5	62.5%	15	8	53.3%	3	3	100.0%	0	3	2.0	-7	4	23	67.4%
1/22	HOU	W 128-122	42	36	2	10	0	3	3	10	2	20.0%	18	13	72.2%	28	15	53.6%	4	4	100.0%	1	1	3.3	+8	1	34	60.5%
1/20	PHX	L 116-110	42	20	2	7	1	3	2	8	2	25.0%	17	5	29.4%	25	7	28.0%	5	4	80.0%	0	2	3.5	+3	3	12	36.8%
1/19	IND	W 113-104	40	29	4	8	1	8	2	4	1	25.0%	20	11	55.0%	24	12	50.0%	4	4	100.0%	1	3	4.0	+16	3	35	56.3%
1/16	CLE	L 117-115	38	22	5	9	2	5	2	8	2	25.0%	15	7	46.7%	23	9	39.1%	2	2	100.0%	1	4	4.5	-4	1	25	46.1%
1/14	CLE	L 133-107	31	14	2	4	2	0	0	8	2	25.0%	8	3	37.5%	16	5	31.3%	2	2	100.0%	0	2	0.0	-22	0	13	41.5%
1/12	TOR	W 115-102	34	33	4	2	0	1	1	9	6	66.7%	7	4	57.1%	16	10	62.5%	7	7	100.0%	1	3	2.0	+13	1	37	86.5%
1/11	TOR	L 116-115	44	38	4	5	2	2	5	7	2	28.6%	20	11	55.0%	27	13	48.1%	12	10	83.3%	0	4	1.0	+17	5	33	58.9%
1/9	ORL	W 103-91	37	29	1	1	0	3	1	8	3	37.5%	14	7	50.0%	22	10	45.5%	6	6	100.0%	0	1	1.0	+7	0	24	58.8%
1/7	WAS	W 131-110	28	22	3	8	1	2	2	10	4	40.0%	5	5	100.0%	15	9	60.0%	1	0	0.0%	0	3	4.0	+20	1	28	71.2%
1/5	DEN	L 125-124	45	28	6	6	2	4	1	9	4	44.4%	13	6	46.2%	22	10	45.5%	6	4	66.7%	0	6	6.0	-1	1	33	56.8%
1/3	NYK	W 130-119	37	36	8	4	2	1	4	9	6	66.7%	13	8	61.5%	22	14	63.6%	4	2	50.0%	0	8	1.0	+6	1	39	75.8%
1/1	DAL	W 123-108	42	34	8	10	2	2	3	10	4	40.0%	14	10	71.4%	24	14	58.3%	2	2	100.0%	0	8	3.3	+18	0	44	68.3%
12/30	MEM	W 139-136	43	34	4	12	0	2	0	7	4	57.1%	14	9	64.3%	21	13	61.9%	5	4	80.0%	1	3	0.0	+2	3	42	73.3%
12/28	OKC	L 129-104	36	28	2	5	0	4	5	7	2	28.6%	11	8	72.7%	18	10	55.6%	7	6	85.7%	0	2	1.0	-22	2	27	66.4%
12/26	CHI	L 109-102	40	27	5	8	2	0	2	11	5	45.5%	13	4	30.8%	24	9	37.5%	4	4	100.0%	0	5	4.0	+0	3	24	52.4%
12/23	BKN	L 114-106	39	13	3	2	0	4	4	5	0	0.0%	9	3	33.3%	14	3	21.4%	7	7	100.0%	0	3	0.5	-19	4	7	38.1%
12/20	DAL	W 121-114	40	38	2	4	1	1	0	11	5	45.5%	20	10	50.0%	31	15	48.4%	3	3	100.0%	0	2	0.0	+0	0	31	58.8%
12/19	NYK	W 116-107	37	30	2	9	0	1	3	12	6	50.0%	12	5	41.7%	24	11	45.8%	2	2	100.0%	0	2	3.0	+7	4	26	60.3%
12/7	LAL	L 112-108	38	28	7	9	2	2	3	8	5	62.5%	16	6	37.5%	24	11	45.8%	2	1	50.0%	0	7	3.0	-9	2	29	56.3%
12/5	MIL	W 116-101	36	12	4	4	1	4	2	3	0	0.0%	11	5	45.5%	14	5	35.7%	2	2	100.0%	2	2	2.0	+16	2	13	40.3%
12/4	GSW	W 99-98	39	35	3	2	1	2	3	10	4	40.0%	17	9	52.9%	27	13	48.1%	5	5	100.0%	0	3	0.7	+7	2	26	59.9%
12/2	WAS	W 121-102	28	35	4	6	1	4	0	9	4	44.4%	17	9	52.9%	26	13	50.0%	5	5	100.0%	0	4	0.0	+23	2	34	62.1%
11/30	ATL	L 142-134	52	44	7	9	1	0	6	13	2	15.4%	18	12	66.7%	31	14	45.2%	17	14	82.4%	0	7	1.5	-8	2	42	57.2%
11/28	BKN	W 115-103	41	22	9	7	1	1	1	8	2	25.0%	8	5	62.5%	16	7	43.8%	6	6	100.0%	0	9	7.0	+8	2	31	59.0%
11/25	ORL	L 144-103	31	20	1	4	0	1	1	5	1	20.0%	10	6	60.0%	15	7	46.7%	6	5	83.3%	0	1	4.0	-30	2	17	56.7%
11/23	MIA	L 127-117	36	27	3	6	0	2	3	14	5	35.7%	9	5	55.6%	23	10	43.5%	2	2	100.0%	0	3	2.0	-14	2	22	56.5%
11/20	MIL	W 123-114	46	54	5	9	3	3	5	15	6	40.0%	15	12	80.0%	30	18	60.0%	14	12	85.7%	0	5	1.8	+18	3	62	74.7%
11/19	TOR	L 121-112	38	24	2	9	1	3	3	9	5	55.6%	5	3	60.0%	14	8	57.1%	4	3	75.0%	1	1	3.0	-2	1	32	76.1%
11/17	LAC	W 110-108	40	39	3	6	0	1	4	11	4	36.4%	16	9	56.3%	27	13	48.1%	10	9	90.0%	0	3	1.5	+4	1	36	62.1%
11/14	DET	L 114-105	39	31	7	3	0	4	3	11	2	18.2%	20	11	55.0%	31	13	41.9%	3	3	100.0%	0	7	1.0	-10	2	22	48.0%
11/11	BOS	W 102-100	33	21	5	9	0	1	0	6	3	50.0%	11	2	18.2%	17	5	29.4%	8	8	100.0%	0	5	0.0	-6	3	24	51.2%
11/9	DET	L 111-108	38	33	4	7	0	2	3	12	4	33.3%	14	6	42.9%	26	10	38.5%	9	9	100.0%	0	4	2.3	-6	3	29	55.1%
11/8	TOR	W 130-120	42	31	4	7	2	1	1	10	3	30.0%	14	9	64.3%	24	12	50.0%	5	4	80.0%	1	3	7.0	+21	3	31	59.2%
11/5	CLE	L 132-121	36	27	7	9	0	1	5	5	2	40.0%	15	8	53.3%	20	10	50.0%	8	5	62.5%	1	6	1.8	-7	2	28	57.4%
11/4	CHI	L 113-111	39	39	5	5	3	1	4	10	6	60.0%	16	8	50.0%	26	14	53.8%	5	5	100.0%	0	5	1.3	+3	2	38	69.1%
11/2	BKN	W 129-105	38	26	6	7	0	1	1	9	4	44.4%	10	5	50.0%	19	9	47.4%	4	4	100.0%	0	6	7.0	+21	3	28	62.6%
10/31	BOS	L 109-108	43	26	8	14	2	2	5	9	4	44.4%	7	4	57.1%	16	8	50.0%	7	6	85.7%	1	7	2.8	+10	2	39	68.1%
10/28	WAS	W 139-134	47	39	3	10	1	1	4	9	3	33.3%	16	8	50.0%	25	11	44.0%	16	14	87.5%	0	3	2.5	+3	3	39	60.9%
10/27	ORL	W 136-124	41	43	4	8	0	1	1	11	4	36.4%	21	11	52.4%	32	15	46.9%	10	9	90.0%	0	4	8.0	+14	1	42	59.1%
10/25	CHA	W 125-121	41	28	6	9	1	0	2	9	4	44.4%	11	3	27.3%	20	7	35.0%	12	10	83.3%	1	5	4.5	+3	3	29	55.4%
10/22	BOS	W 117-116	41	40	2	6	1	2	1	9	7	77.8%	15	6	40.0%	24	13	54.2%	8	7	87.5%	0	2	6.0	+3	5	35	72.7%
Regular Season Totals			38.2	28.4	4.2	6.7	0.8	1.9	2.4	8.6	3.2	36.7%	13.0	6.8	52.3%	21.6	9.9	46.1%	6.0	5.3	89.1%	0.3	3.8	2.8	+100	2.2	31.3	58.6%

Postseason
Date	Opp	Result	MIN	PTS	REB	AST	BLK	STL	TO	3PA	3PM	3P%	2PA	2PM	2P%	FGA	FGM	FG%	FTA	FTM	FT%	OREB	DREB	A/TO	+/-	PF	PER	TS%
5/4	NYK	L 137-98	26	13	3	2	0	0	4	3	0	0.0%	6	3	50.0%	9	3	33.3%	7	7	100.0%	1	2	0.5	-28	1	10	53.8%
5/2	BOS	W 109-100	45	30	11	7	0	0	1	4	2	50.0%	14	9	64.3%	18	11	61.1%	6	6	100.0%	0	11	7.0	+8	4	38	72.7%
4/30	BOS	W 106-93	39	30	2	5	0	2	0	5	3	60.0%	17	8	47.1%	22	11	50.0%	5	5	100.0%	1	1	0.0	+15	1	29	62.0%
4/28	BOS	W 113-97	42	25	10	5	1	2	2	10	3	30.0%	8	7	87.5%	18	10	55.6%	2	2	100.0%	0	10	2.5	+15	1	34	66.2%
4/26	BOS	L 128-96	40	22	2	6	1	0	1	7	4	57.1%	7	3	42.9%	14	7	50.0%	4	4	100.0%	0	2	6.0	-22	3	21	69.8%
4/24	BOS	L 108-100	42	31	4	6	2	1	1	13	5	38.5%	18	7	38.9%	31	12	38.7%	2	2	100.0%	1	3	6.0	-5	1	20	48.6%
4/21	BOS	W 111-97	39	29	4	9	0	2	1	12	5	41.7%	16	6	37.5%	28	11	39.3%	2	2	100.0%	1	3	9.0	+6	2	28	50.2%
4/19	BOS	L 123-91	36	21	1	8	0	0	3	4	1	25.0%	16	7	43.8%	20	8	40.0%	5	4	80.0%	0	1	2.7	-29	4	15	47.3%
Postseason Totals			39.1	25.1	4.6	6.0	0.5	0.9	1.6	7.3	2.9	39.7%	12.8	6.3	49.0%	20.0	9.1	45.6%	4.1	4.0	97.0%	0.5	4.1	3.7	-40	2.1	27.9	57.6%

Tyrese Maxey: Breaking News

Maxey registered 13 points (3-9 FG, 0-3 3Pt, 7-7 FT), three rebounds and two assists across 27 minutes during Monday's 137-98 loss to the Knicks in Game 1 of the Eastern Conference Semifinals. After posting a 30-point, 11-rebound double-double in Saturday's Game 7 win over Boston in the first round, Maxey cooled off Monday. The star point guard struggled to find a rhythm on the offensive end, failing to reach the 20-point threshold for the first time this postseason. He was one of five Philadelphia players to score in double figures, though none had more than 17. Maxey will look to bounce back in Game 2 on Wednesday.

Maxey provided 30 points (11-18 FG, 2-4 3Pt, 6-6 FT), 11 rebounds and seven assists across 45 minutes during Saturday's 109-100 victory over Boston in Game 7 of the first round of the Eastern Conference playoffs. Maxey put a bow on what was an elite first-round series, scoring at least 30 points for the second straight game while also pulling down a season-high 11 rebounds. He averaged 26.9 points, 4.9 rebounds, 6.6 assists, 1.0 steals and 3.3 three-pointers in the series. Heading into the second round against New York, Maxey may need to take his game to yet another level, especially if Joel Embiid is limited due to a knee concern stemming from Game 7.

Maxey accumulated 30 points (11-22 FG, 3-5 3Pt, 5-5 FT), two rebounds, five assists and two steals in 40 minutes during Thursday's 106-93 victory over the Celtics in Game 6 of the first round of the Eastern Conference playoffs. Maxey led the charge for Philly on the offensive end by scoring 30 points for the second time this series. He was much more efficient from beyond the arc after going 3-for-10 from distance in Game 5, and he's now drilled three or more treys in five straight appearances. The Sixers will need more of the same from Maxey on Saturday in Game 7 to advance to the next round.